Design, synthesis and evaluation of N2,N4-diaminoquinazoline based inhibitors of phosphodiesterase type 5
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (2) , 267-270
Abstract
No abstract availableKeywords
Funding Information
- Thailand Research Fund (RSA6100073, DBG5980001, IRN61W0005)
- King Mongkut’s Institute of Technology Ladkrabang
- Kasetsart University Research and Development Institute
- Development and Promotion of Science and Technology
This publication has 29 references indexed in Scilit:
- Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2013
- Design, Synthesis, and Pharmacological Evaluation of Monocyclic Pyrimidinones as Novel Inhibitors of PDE5Journal of Medicinal Chemistry, 2012
- Erectile Dysfunction and Hypertension: Impact on Cardiovascular Risk and TreatmentInternational Journal of Hypertension, 2012
- Phosphodiesterase Inhibitors as a New Generation of Antiprotozoan Drugs: Exploiting the Benefit of Enzymes that are Highly Conserved Between Host and ParasiteFuture Medicinal Chemistry, 2011
- Thousands of chemical starting points for antimalarial lead identificationNature, 2010
- 1-(2-(2,2,2-Trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitorsBioorganic & Medicinal Chemistry Letters, 2010
- Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring systemBioorganic & Medicinal Chemistry Letters, 2009
- A Novel Series of Potent and Selective PDE5 Inhibitors with Potential for High and Dose-Independent Oral BioavailabilityJournal of Medicinal Chemistry, 2006
- Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunctionBioorganic & Medicinal Chemistry Letters, 2004
- Identification, Quantitation, and Cellular Localization of PDE1 Calmodulin-Stimulated Cyclic Nucleotide PhosphodiesterasesMethods, 1998